Description

Lapatinib is an oral targeted therapy used to treat HER2-positive breast cancer. It inhibits the activity of the HER2 receptor, slowing cancer cell growth and proliferation. Often combined with other treatments, Lapatinib improves outcomes and prolongs survival for affected patients.